US FDA Approves Celltrion's Zymfentra for Bowel Disease

Celltrion USA announced that the US Food and Drug Administration (FDA) has approved

IISER Bhopal Scientist Develop Biomedical Adhesive to fix Tissues

Researchers at the Indian Institute of Science Education and Research Bhopal, also known as IISER

US FDA Approves AstraZeneca's sBLA for Self-administration

The US Food and Drug Administration (FDA) has accepted AstraZeneca's Supplemental Biologics

DoP Implementing Operational Guidelines Under PLI Scheme

The Department of Pharmaceuticals (DoP) has made changes to the operational guidelines for the pharmaceutical production

AstraZeneca's Self-administered Flu Vaccine to be Approved by FDA

FluMist, AstraZeneca's nasal spray flu vaccination that has been on the market for two decades, might be ready for self-administration as soon as next year.

Torrent Pharma Net profit Rises 24% To Rs 386 Crore

Torrent Pharmaceuticals Ltd recorded a consolidated net profit of 386 crore for the September quarter, up 24% from the previous year, while revenue increased 16% from 2,291 crore to 2,660 crore. Its earnings before interest, taxes, depreciation...

Lupin Secures US FDA Approval for Fluconazole Tablets, USP

Lupin Limited (Lupin) announced that the United States Food and Drug Administration

Roche Signs Definitive Agreement To Acquire Telavant Holdings

Roche has announced the signing of a formal agreement to purchase Telavant Holdings, Inc.

US FDA Approves Vaxcyte's IND Application For VAX-31

Vaxcyte, Inc., a vaccine innovation company that develops b>high-fidelity vaccines to protect humans from the consequences of bacterial diseases, announced that the FDA has approved the company's adult Investigational New Drug (IND)...

LMDX, AstraZeneca & Everton Partner For Heart & Lung screening Hub

LumiraDx (LMDX) Limited announced a strategic partnership with AstraZeneca and Everton in the Community to launch England's first community-based heart and lung screening hub in November. The official charity of Everton Football Club will run this...

© 2024 India Pharma Outlook. All Rights Reserved.